US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IN8bio, Inc.

1.66

-0.3400-17.00%

Post-market: 1.710.0500+3.01%19:13 EDT

Volume:239.67K

Turnover:403.35K

Market Cap:16.35M

PE:-0.37

High:2.00

Open:2.00

Low:1.58

Close:2.00

52wk High:7.20

52wk Low:1.17

Shares:9.85M

Float Shares:9.15M

Volume Ratio:2.48

T/O Rate:2.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.4441

EPS(LYR):-4.4441

ROE:-92.49%

ROA:-46.64%

PB:0.59

PE(LYR):-0.37

Loading ...

Overview Company News Filings

IN8BIO Inc. publishes corporate presentation on gamma-delta T cell therapies in oncology and autoimmune diseases

IN8bio Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026

IN8bio Inc expected to post a loss of 62 cents a share - Earnings Preview

IN8bio Announces Board Resignation and Interim Chair Appointment

IN8bio Inc - Jeremy Graff Appointed Interim Chair of Board - SEC Filing

THOMSON REUTERS

IN8bio Inc - Alan S. Roemer Resigns as Director of IN8bio - SEC Filing

THOMSON REUTERS

IN8bio Names Jeremy Graff Interim Board Chair as Alan Roemer Resigns

IN8BIO ernennt Kate Rochlin zur Präsidentin und Chief Operating Officer

Press Release: IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

IN8BIO Showcases DeltEx Immunotherapy Results at IO360° Conference

IN8BIO präsentiert neue Ergebnisse zur Immuntherapie gegen solide Tumoren auf Fachkonferenzen

IN8bio (INAB) Receives a Buy from JonesTrading

IN8bio files to sell 14.38M shares of common stock for holders

IN8BIO Inc. unveils presentation on advancing gamma-delta T cell therapies for cancer

IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating

IN8bio presents Phase I/II data from INB-200 trials

IN8bio Inc - Delttex Immunotherapy Doubles Median Progression-Free Survival to 13 Months

THOMSON REUTERS

IN8bio Inc - Delttex Treatment Shows No Severe Adverse Events or Toxicities

THOMSON REUTERS

IN8bio Gamma-Delta T Cell Therapy Nearly Doubles Progression-Free Survival in Glioblastoma Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INAB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.66,"timestamp":1774296000000,"preClose":2,"halted":0,"volume":239669,"hourTrading":{"tag":"盘后","latestPrice":1.71,"preClose":1.66,"latestTime":"19:13 EDT","volume":354,"amount":601.4549916,"timestamp":1774307635615,"change":0.05,"changeRate":0.03012,"amplitude":0.048193},"delay":0,"changeRate":-0.17000000000000004,"floatShares":9150700,"shares":9847089,"eps":-4.444111,"marketStatus":"Post-Mkt","change":-0.34,"latestTime":"03-23 19:18:32 EDT","open":2,"high":2,"low":1.58,"amount":403349.0980987,"amplitude":0.21,"askPrice":1.85,"askSize":100,"bidPrice":1.56,"bidSize":71,"shortable":0,"etf":0,"ttmEps":-4.444111,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774310400000},"marketStatusCode":4,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":2,"preHourTrading":{"tag":"盘前","latestPrice":1.99,"preClose":2,"latestTime":"08:37 EDT","volume":236,"amount":470.85832639999995,"timestamp":1774269434622,"change":-0.01,"changeRate":-0.005,"amplitude":0.025},"postHourTrading":{"tag":"盘后","latestPrice":1.71,"preClose":1.66,"latestTime":"19:13 EDT","volume":354,"amount":601.4549916,"timestamp":1774307635615,"change":0.05,"changeRate":0.03012,"amplitude":0.048193},"volumeRatio":2.475295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","floatShares":9150700,"roa":"-46.64%","roe":"-92.49%","lyrEps":-4.444111,"volumeRatio":2.475295,"shares":9847089,"dividePrice":0,"high":2,"amplitude":0.21,"preClose":2,"low":1.58,"week52Low":1.17,"pbRate":"0.59","week52High":7.2,"institutionHeld":0,"latestPrice":1.66,"committee":-0.169591,"eps":-4.444111,"divideRate":0,"volume":239669,"delay":0,"ttmEps":-4.444111,"open":2,"prevYearClose":2.34,"prevWeekClose":2,"prevMonthClose":1.7,"prevQuarterClose":2.34,"fiveDayClose":2.06,"twentyDayClose":1.51,"sixtyDayClose":1.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-12","symbol":"INAB","fiscalQuarterEnding":"2025/12","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"INAB","fiscalQuarterEnding":"2025/09","expectedEps":-1.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-08-07","symbol":"INAB","fiscalQuarterEnding":"2025/06","expectedEps":-1.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-1.24},{"market":"US","date":"2025-06-06","symbol":"INAB","defaultRemindTime":1749216600000,"type":"split","dateTimestamp":1749182400000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-05-07","symbol":"INAB","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1768622400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INAB","date":"2026-03-20","current":-0.373528,"percent":0.672203,"low":-22.35346,"twenty":-2.637064,"median":-1.442574,"eighty":-0.491833,"high":-0.259966,"avg":-2.836281,"sd":4.150445,"marketCap":16936993},"quantilePoints":[{"date":"2021-07-30","current":-20.321327,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":187545530},{"date":"2021-08-06","current":-19.792973,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":182669346},{"date":"2021-08-13","current":-19.000441,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":175355070},{"date":"2021-08-20","current":-15.667743,"twenty":-60.555129,"median":-60.555129,"eighty":-60.555129,"marketCap":144597603},{"date":"2021-08-27","current":-14.936176,"twenty":-60.555129,"median":-60.555129,"eighty":-22.35346,"marketCap":137845964},{"date":"2021-09-03","current":-16.907344,"twenty":-60.555129,"median":-60.555129,"eighty":-20.215656,"marketCap":156037880},{"date":"2021-09-10","current":-17.727589,"twenty":-60.555129,"median":-60.555129,"eighty":-20.040893,"marketCap":166727976},{"date":"2021-09-17","current":-13.958732,"twenty":-60.555129,"median":-60.555129,"eighty":-19.085791,"marketCap":131281871},{"date":"2021-09-24","current":-15.155194,"twenty":-60.555129,"median":-60.555129,"eighty":-18.138817,"marketCap":142534602},{"date":"2021-10-01","current":-14.736432,"twenty":-60.555129,"median":-60.555129,"eighty":-17.663778,"marketCap":138596146},{"date":"2021-10-08","current":-12.881915,"twenty":-60.555129,"median":-60.555129,"eighty":-16.140999,"marketCap":121154412},{"date":"2021-10-15","current":-11.984369,"twenty":-60.555129,"median":-60.555129,"eighty":-15.651486,"marketCap":112712988},{"date":"2021-10-22","current":-13.280736,"twenty":-60.555129,"median":-60.555129,"eighty":-14.97998,"marketCap":124905322},{"date":"2021-10-29","current":-15.135253,"twenty":-60.555129,"median":-60.555129,"eighty":-14.672621,"marketCap":142347057},{"date":"2021-11-05","current":-14.955784,"twenty":-60.555129,"median":-60.555129,"eighty":-14.748397,"marketCap":140659147},{"date":"2021-11-12","current":-14.224101,"twenty":-60.555129,"median":-60.555129,"eighty":-14.60881,"marketCap":158100881},{"date":"2021-11-19","current":-11.473771,"twenty":-60.555129,"median":-22.35346,"eighty":-14.426892,"marketCap":127530960},{"date":"2021-11-26","current":-11.389405,"twenty":-60.555129,"median":-22.35346,"eighty":-13.958732,"marketCap":126593232},{"date":"2021-12-03","current":-9.448987,"twenty":-60.555129,"median":-20.321327,"eighty":-13.818503,"marketCap":105025496},{"date":"2021-12-10","current":-11.170053,"twenty":-60.555129,"median":-20.199399,"eighty":-13.58292,"marketCap":124155140},{"date":"2021-12-17","current":-10.36014,"twenty":-60.555129,"median":-20.04699,"eighty":-13.380441,"marketCap":115152955},{"date":"2021-12-23","current":-10.377013,"twenty":-60.555129,"median":-19.843776,"eighty":-13.252819,"marketCap":115340500},{"date":"2021-12-31","current":-7.407331,"twenty":-60.555129,"median":-19.000441,"eighty":-12.570834,"marketCap":82332487},{"date":"2022-01-07","current":-7.230163,"twenty":-60.555129,"median":-18.461926,"eighty":-12.206067,"marketCap":80363259},{"date":"2022-01-14","current":-6.833643,"twenty":-60.555129,"median":-17.887117,"eighty":-11.984528,"marketCap":75955939},{"date":"2022-01-21","current":-5.419838,"twenty":-60.555129,"median":-17.727589,"eighty":-11.677476,"marketCap":60241499},{"date":"2022-01-28","current":-5.061958,"twenty":-60.555129,"median":-16.898705,"eighty":-11.301664,"marketCap":56263659},{"date":"2022-02-04","current":-5.483787,"twenty":-60.555129,"median":-16.175776,"eighty":-10.967575,"marketCap":60952297},{"date":"2022-02-11","current":-7.069867,"twenty":-60.555129,"median":-15.983021,"eighty":-10.387137,"marketCap":78581577},{"date":"2022-02-18","current":-6.81677,"twenty":-60.555129,"median":-15.647422,"eighty":-10.120541,"marketCap":75768394},{"date":"2022-02-25","current":-7.322965,"twenty":-60.555129,"median":-15.411038,"eighty":-9.418616,"marketCap":81394760},{"date":"2022-03-04","current":-7.13736,"twenty":-60.555129,"median":-15.198094,"eighty":-9.287005,"marketCap":79331759},{"date":"2022-03-11","current":-5.399421,"twenty":-60.555129,"median":-15.055489,"eighty":-7.731297,"marketCap":60014569},{"date":"2022-03-18","current":-3.748845,"twenty":-60.555129,"median":-14.955784,"eighty":-7.444452,"marketCap":54931819},{"date":"2022-03-25","current":-4.288062,"twenty":-60.555129,"median":-14.796256,"eighty":-7.302717,"marketCap":62832971},{"date":"2022-04-01","current":-4.416447,"twenty":-60.555129,"median":-14.626756,"eighty":-7.171106,"marketCap":64714198},{"date":"2022-04-08","current":-5.289466,"twenty":-60.555129,"median":-14.428142,"eighty":-7.076617,"marketCap":77506540},{"date":"2022-04-14","current":-4.4687,"twenty":-60.555129,"median":-14.426579,"eighty":-6.951755,"marketCap":65479857},{"date":"2022-04-22","current":-4.64754,"twenty":-60.555129,"median":-14.038496,"eighty":-6.889324,"marketCap":68100406},{"date":"2022-04-29","current":-3.081242,"twenty":-60.555129,"median":-13.958732,"eighty":-6.820145,"marketCap":45149440},{"date":"2022-05-06","current":-3.346101,"twenty":-60.555129,"median":-13.77786,"eighty":-6.48268,"marketCap":49030411},{"date":"2022-05-13","current":-2.840843,"twenty":-60.555129,"median":-13.659616,"eighty":-6.014858,"marketCap":52370949},{"date":"2022-05-20","current":-2.237931,"twenty":-60.555129,"median":-13.521562,"eighty":-5.632272,"marketCap":41256251},{"date":"2022-05-27","current":-2.411651,"twenty":-60.555129,"median":-13.380441,"eighty":-5.517534,"marketCap":44458791},{"date":"2022-06-03","current":-2.707998,"twenty":-60.555129,"median":-13.280736,"eighty":-5.419838,"marketCap":49921948},{"date":"2022-06-10","current":-2.452527,"twenty":-60.555129,"median":-13.051414,"eighty":-5.315055,"marketCap":45212330},{"date":"2022-06-17","current":-2.3299,"twenty":-60.555129,"median":-12.582799,"eighty":-5.161081,"marketCap":42951713},{"date":"2022-06-24","current":-2.483183,"twenty":-60.555129,"median":-12.363448,"eighty":-4.711057,"marketCap":45777484},{"date":"2022-07-01","current":-2.268587,"twenty":-60.555129,"median":-12.190881,"eighty":-4.552535,"marketCap":41821405},{"date":"2022-07-08","current":-2.499738,"twenty":-60.555129,"median":-12.131058,"eighty":-4.42415,"marketCap":46082667},{"date":"2022-07-15","current":-2.217493,"twenty":-60.555129,"median":-11.984369,"eighty":-4.339416,"marketCap":40879482},{"date":"2022-07-22","current":-2.457636,"twenty":-60.555129,"median":-11.64557,"eighty":-4.254681,"marketCap":45306522},{"date":"2022-07-29","current":-2.595591,"twenty":-60.555129,"median":-11.473771,"eighty":-4.172515,"marketCap":47849716},{"date":"2022-08-05","current":-2.452527,"twenty":-60.555129,"median":-11.170053,"eighty":-3.923449,"marketCap":45212330},{"date":"2022-08-12","current":-1.544548,"twenty":-60.555129,"median":-11.035068,"eighty":-3.402872,"marketCap":34851171},{"date":"2022-08-19","current":-1.998049,"twenty":-60.555129,"median":-10.75666,"eighty":-3.158273,"marketCap":45083968},{"date":"2022-08-26","current":-2.128356,"twenty":-60.555129,"median":-10.377013,"eighty":-2.846974,"marketCap":48024227},{"date":"2022-09-02","current":-2.617009,"twenty":-60.555129,"median":-10.284211,"eighty":-2.79112,"marketCap":59050198},{"date":"2022-09-09","current":-2.682163,"twenty":-60.555129,"median":-9.879254,"eighty":-2.656101,"marketCap":60520327},{"date":"2022-09-16","current":-2.725599,"twenty":-60.555129,"median":-9.398368,"eighty":-2.67239,"marketCap":61500414},{"date":"2022-09-23","current":-2.160933,"twenty":-60.555129,"median":-9.330876,"eighty":-2.636466,"marketCap":48759292},{"date":"2022-09-30","current":-2.19351,"twenty":-60.555129,"median":-7.947273,"eighty":-2.595591,"marketCap":49494357},{"date":"2022-10-07","current":-2.258664,"twenty":-60.555129,"median":-7.736358,"eighty":-2.505541,"marketCap":50964486},{"date":"2022-10-14","current":-2.182651,"twenty":-60.555129,"median":-7.474824,"eighty":-2.483183,"marketCap":49249335},{"date":"2022-10-21","current":-1.607126,"twenty":-60.555129,"median":-7.415767,"eighty":-2.467985,"marketCap":36263192},{"date":"2022-10-28","current":-2.008908,"twenty":-60.555129,"median":-7.322965,"eighty":-2.452568,"marketCap":45328990},{"date":"2022-11-04","current":-1.954613,"twenty":-60.555129,"median":-7.225945,"eighty":-2.452527,"marketCap":44103882},{"date":"2022-11-11","current":-1.576798,"twenty":-45.274461,"median":-7.13736,"eighty":-2.40552,"marketCap":41898688},{"date":"2022-11-18","current":-1.318609,"twenty":-22.35346,"median":-7.086741,"eighty":-2.353137,"marketCap":35038084},{"date":"2022-11-25","current":-1.493809,"twenty":-22.35346,"median":-7.044557,"eighty":-2.336787,"marketCap":39693494},{"date":"2022-12-02","current":-1.954861,"twenty":-22.35346,"median":-6.951755,"eighty":-2.319682,"marketCap":51944572},{"date":"2022-12-09","current":-2.176166,"twenty":-21.947033,"median":-6.91379,"eighty":-2.291069,"marketCap":57825090},{"date":"2022-12-16","current":-1.576798,"twenty":-20.321327,"median":-6.867389,"eighty":-2.277598,"marketCap":41898688},{"date":"2022-12-23","current":-1.632125,"twenty":-20.30507,"median":-6.825207,"eighty":-2.25851,"marketCap":43368817},{"date":"2022-12-30","current":-2.130061,"twenty":-20.240042,"median":-6.79146,"eighty":-2.249935,"marketCap":56599982},{"date":"2023-01-06","current":-2.609555,"twenty":-20.207528,"median":-6.500397,"eighty":-2.249578,"marketCap":69341104},{"date":"2023-01-13","current":-2.130061,"twenty":-20.101857,"median":-6.293701,"eighty":-2.248149,"marketCap":56599982},{"date":"2023-01-20","current":-2.139282,"twenty":-20.065278,"median":-6.008422,"eighty":-2.222649,"marketCap":56845004},{"date":"2023-01-27","current":-2.102398,"twenty":-20.044957,"median":-5.763894,"eighty":-2.196076,"marketCap":55864917},{"date":"2023-02-03","current":-2.231493,"twenty":-19.951479,"median":-5.568153,"eighty":-2.194169,"marketCap":59295219},{"date":"2023-02-10","current":-1.779661,"twenty":-19.833615,"median":-5.517534,"eighty":-2.176617,"marketCap":47289163},{"date":"2023-02-17","current":-1.800593,"twenty":-19.573503,"median":-5.483787,"eighty":-2.16454,"marketCap":47845361},{"date":"2023-02-24","current":-1.346272,"twenty":-19.25649,"median":-5.405012,"eighty":-2.156798,"marketCap":35773149},{"date":"2023-03-03","current":-1.456925,"twenty":-18.976055,"median":-5.348802,"eighty":-2.139282,"marketCap":38713408},{"date":"2023-03-10","current":-1.171073,"twenty":-18.760649,"median":-5.247563,"eighty":-2.137131,"marketCap":31117739},{"date":"2023-03-17","current":-1.078862,"twenty":-18.468022,"median":-5.111519,"eighty":-2.129038,"marketCap":28667523},{"date":"2023-03-24","current":-1.134188,"twenty":-18.28513,"median":-4.724571,"eighty":-2.11729,"marketCap":30137653},{"date":"2023-03-31","current":-1.116819,"twenty":-17.994243,"median":-4.628283,"eighty":-2.093853,"marketCap":31852804},{"date":"2023-04-06","current":-1.013728,"twenty":-17.857797,"median":-4.525575,"eighty":-2.054716,"marketCap":28912545},{"date":"2023-04-14","current":-1.108228,"twenty":-17.737933,"median":-4.429286,"eighty":-2.044514,"marketCap":31607782},{"date":"2023-04-21","current":-0.9793,"twenty":-17.711636,"median":-4.39077,"eighty":-2.024631,"marketCap":27930624},{"date":"2023-04-28","current":-1.600107,"twenty":-17.499729,"median":-4.3009,"eighty":-2.010187,"marketCap":45636646},{"date":"2023-05-05","current":-2.002319,"twenty":-16.903888,"median":-4.281643,"eighty":-2.008908,"marketCap":57108152},{"date":"2023-05-12","current":-1.906138,"twenty":-16.800043,"median":-4.223869,"eighty":-2.008908,"marketCap":54364966},{"date":"2023-05-19","current":-3.134129,"twenty":-16.387118,"median":-4.172515,"eighty":-2.008908,"marketCap":93713596},{"date":"2023-05-26","current":-2.576951,"twenty":-16.167082,"median":-4.031292,"eighty":-2.009164,"marketCap":77053401},{"date":"2023-06-02","current":-3.044583,"twenty":-16.132305,"median":-3.87723,"eighty":-2.010187,"marketCap":91036064},{"date":"2023-06-09","current":-2.397858,"twenty":-16.013206,"median":-3.466397,"eighty":-2.010187,"marketCap":71698338},{"date":"2023-06-16","current":-2.109319,"twenty":-15.952836,"median":-3.338012,"eighty":-2.010187,"marketCap":63070737},{"date":"2023-06-23","current":-1.910326,"twenty":-15.724762,"median":-3.218941,"eighty":-2.008908,"marketCap":57120668},{"date":"2023-06-30","current":-1.611838,"twenty":-15.65555,"median":-3.138239,"eighty":-2.001778,"marketCap":48195563},{"date":"2023-07-07","current":-1.661586,"twenty":-15.570177,"median":-3.134129,"eighty":-1.998049,"marketCap":49683081},{"date":"2023-07-14","current":-1.691435,"twenty":-15.437001,"median":-3.034633,"eighty":-1.966279,"marketCap":50575591},{"date":"2023-07-21","current":-1.591939,"twenty":-15.343021,"median":-2.997073,"eighty":-1.948098,"marketCap":47600556},{"date":"2023-07-28","current":-1.238727,"twenty":-15.240995,"median":-2.910292,"eighty":-1.927198,"marketCap":37039183},{"date":"2023-08-04","current":-1.263601,"twenty":-15.206675,"median":-2.86549,"eighty":-1.903019,"marketCap":37782941},{"date":"2023-08-11","current":-1.144206,"twenty":-15.147218,"median":-2.826657,"eighty":-1.879294,"marketCap":34212900},{"date":"2023-08-18","current":-1.183602,"twenty":-15.103347,"median":-2.765993,"eighty":-1.844935,"marketCap":36025305},{"date":"2023-08-25","current":-1.059013,"twenty":-15.015607,"median":-2.720922,"eighty":-1.788034,"marketCap":32233167},{"date":"2023-09-01","current":-1.09016,"twenty":-14.955784,"median":-2.706296,"eighty":-1.751998,"marketCap":33181202},{"date":"2023-09-08","current":-1.005128,"twenty":-14.955784,"median":-2.665875,"eighty":-1.734645,"marketCap":30593068},{"date":"2023-09-15","current":-0.975953,"twenty":-14.951862,"median":-2.637688,"eighty":-1.702114,"marketCap":29705076},{"date":"2023-09-22","current":-1.204367,"twenty":-14.908192,"median":-2.636466,"eighty":-1.688248,"marketCap":36657328},{"date":"2023-09-29","current":-1.152455,"twenty":-14.784291,"median":-2.613282,"eighty":-1.672875,"marketCap":35077270},{"date":"2023-10-06","current":-1.017587,"twenty":-14.720479,"median":-2.595591,"eighty":-1.660148,"marketCap":30972282},{"date":"2023-10-13","current":-0.986335,"twenty":-14.644703,"median":-2.581926,"eighty":-1.631815,"marketCap":30021087},{"date":"2023-10-20","current":-0.996718,"twenty":-14.592857,"median":-2.545008,"eighty":-1.604995,"marketCap":30337099},{"date":"2023-10-27","current":-1.038248,"twenty":-14.58488,"median":-2.535787,"eighty":-1.598161,"marketCap":31601145},{"date":"2023-11-03","current":-1.038248,"twenty":-14.487647,"median":-2.512992,"eighty":-1.579913,"marketCap":31601145},{"date":"2023-11-10","current":-1.04863,"twenty":-14.428142,"median":-2.508124,"eighty":-1.53388,"marketCap":31917156},{"date":"2023-11-17","current":-0.975284,"twenty":-14.427204,"median":-2.499738,"eighty":-1.499342,"marketCap":29460407},{"date":"2023-11-24","current":-0.773116,"twenty":-14.345588,"median":-2.483183,"eighty":-1.472685,"marketCap":23353524},{"date":"2023-12-01","current":-0.879023,"twenty":-14.181765,"median":-2.475843,"eighty":-1.42357,"marketCap":26552637},{"date":"2023-12-08","current":-1.045507,"twenty":-14.054449,"median":-2.460191,"eighty":-1.396066,"marketCap":31581643},{"date":"2023-12-15","current":-2.478208,"twenty":-13.958732,"median":-2.457636,"eighty":-1.392378,"marketCap":74859244},{"date":"2023-12-22","current":-1.846609,"twenty":-13.958732,"median":-2.452578,"eighty":-1.396066,"marketCap":55780526},{"date":"2023-12-29","current":-2.032702,"twenty":-13.958732,"median":-2.452527,"eighty":-1.401599,"marketCap":61401819},{"date":"2024-01-05","current":-1.989757,"twenty":-13.925599,"median":-2.452527,"eighty":-1.402377,"marketCap":60104598},{"date":"2024-01-12","current":-2.204479,"twenty":-13.852506,"median":-2.432089,"eighty":-1.40765,"marketCap":66590705},{"date":"2024-01-19","current":-2.063553,"twenty":-13.785989,"median":-2.419201,"eighty":-1.41082,"marketCap":62333748},{"date":"2024-01-26","current":-1.86293,"twenty":-13.736241,"median":-2.404062,"eighty":-1.42357,"marketCap":56273522},{"date":"2024-02-02","current":-1.719628,"twenty":-13.704713,"median":-2.380995,"eighty":-1.448386,"marketCap":51944790},{"date":"2024-02-09","current":-1.748288,"twenty":-13.628938,"median":-2.367158,"eighty":-1.456925,"marketCap":52810536},{"date":"2024-02-16","current":-1.576325,"twenty":-13.58292,"median":-2.350965,"eighty":-1.460613,"marketCap":47616057},{"date":"2024-02-23","current":-1.447353,"twenty":-13.558377,"median":-2.345229,"eighty":-1.458769,"marketCap":43720198},{"date":"2024-03-01","current":-1.590655,"twenty":-13.444252,"median":-2.3299,"eighty":-1.456925,"marketCap":48048930},{"date":"2024-03-08","current":-1.748288,"twenty":-13.380441,"median":-2.319682,"eighty":-1.458769,"marketCap":52810536},{"date":"2024-03-15","current":-1.662307,"twenty":-13.376453,"median":-2.304353,"eighty":-1.46812,"marketCap":50213297},{"date":"2024-03-22","current":-1.803218,"twenty":-13.344547,"median":-2.289025,"eighty":-1.47731,"marketCap":54109156},{"date":"2024-03-28","current":-1.745515,"twenty":-13.280736,"median":-2.278806,"eighty":-1.482493,"marketCap":52377663},{"date":"2024-04-05","current":-1.615683,"twenty":-13.260795,"median":-2.273092,"eighty":-1.493809,"marketCap":48481804},{"date":"2024-04-12","current":-1.65896,"twenty":-13.220913,"median":-2.258664,"eighty":-1.493809,"marketCap":49780423},{"date":"2024-04-19","current":-1.514703,"twenty":-12.881915,"median":-2.256631,"eighty":-1.482493,"marketCap":45451691},{"date":"2024-04-26","current":-1.500277,"twenty":-12.662564,"median":-2.248149,"eighty":-1.482493,"marketCap":45018818},{"date":"2024-05-03","current":-1.496325,"twenty":-12.582799,"median":-2.24304,"eighty":-1.482493,"marketCap":44900232},{"date":"2024-05-10","current":-1.432162,"twenty":-12.522976,"median":-2.231493,"eighty":-1.471426,"marketCap":44460034},{"date":"2024-05-17","current":-1.446342,"twenty":-12.363448,"median":-2.22179,"eighty":-1.466146,"marketCap":44900232},{"date":"2024-05-24","current":-1.47456,"twenty":-12.249186,"median":-2.21305,"eighty":-1.460522,"marketCap":45776227},{"date":"2024-05-31","current":-1.463976,"twenty":-12.22279,"median":-2.204479,"eighty":-1.456925,"marketCap":45447667},{"date":"2024-06-07","current":-1.606109,"twenty":-12.175695,"median":-2.195832,"eighty":-1.459803,"marketCap":49860062},{"date":"2024-06-14","current":-2.387844,"twenty":-12.164651,"median":-2.194059,"eighty":-1.462594,"marketCap":74128234},{"date":"2024-06-21","current":-1.307913,"twenty":-12.137654,"median":-2.185365,"eighty":-1.456925,"marketCap":40602857},{"date":"2024-06-28","current":-1.278207,"twenty":-12.111271,"median":-2.180423,"eighty":-1.456032,"marketCap":39680667},{"date":"2024-07-05","current":-1.134937,"twenty":-12.029972,"median":-2.177406,"eighty":-1.446342,"marketCap":35232973},{"date":"2024-07-12","current":-1.194064,"twenty":-11.984449,"median":-2.176166,"eighty":-1.442646,"marketCap":37068529},{"date":"2024-07-15","current":-1.247649,"twenty":-11.984409,"median":-2.173979,"eighty":-1.442545,"marketCap":38732002},{"date":"2024-08-02","current":-1.208135,"twenty":-11.984369,"median":-2.171792,"eighty":-1.44243,"marketCap":37505356},{"date":"2024-08-09","current":-0.972336,"twenty":-11.964627,"median":-2.163939,"eighty":-1.432162,"marketCap":30185193},{"date":"2024-08-16","current":-0.882654,"twenty":-11.805099,"median":-2.157724,"eighty":-1.410954,"marketCap":28207850},{"date":"2024-08-23","current":-0.761433,"twenty":-11.486042,"median":-2.153127,"eighty":-1.401599,"marketCap":24333891},{"date":"2024-08-30","current":-0.760116,"twenty":-11.473771,"median":-2.145961,"eighty":-1.383157,"marketCap":24291783},{"date":"2024-09-06","current":-0.49469,"twenty":-11.473771,"median":-2.139282,"eighty":-1.363657,"marketCap":15809309},{"date":"2024-09-13","current":-0.440961,"twenty":-11.406278,"median":-2.139215,"eighty":-1.340739,"marketCap":14092228},{"date":"2024-09-20","current":-0.470095,"twenty":-11.213923,"median":-2.135742,"eighty":-1.289457,"marketCap":15023289},{"date":"2024-09-27","current":-0.417244,"twenty":-11.170053,"median":-2.130061,"eighty":-1.276954,"marketCap":13334280},{"date":"2024-10-04","current":-0.3865,"twenty":-11.143056,"median":-2.126474,"eighty":-1.252451,"marketCap":12351754},{"date":"2024-10-11","current":-0.336577,"twenty":-11.055316,"median":-2.117497,"eighty":-1.235515,"marketCap":10756319},{"date":"2024-10-18","current":-0.33687,"twenty":-10.900082,"median":-2.109319,"eighty":-1.21758,"marketCap":10765676},{"date":"2024-10-25","current":-0.468631,"twenty":-10.812342,"median":-2.095323,"eighty":-1.203755,"marketCap":14976502},{"date":"2024-10-31","current":-0.39543,"twenty":-10.748223,"median":-2.092695,"eighty":-1.194032,"marketCap":12637154},{"date":"2024-11-08","current":-0.484003,"twenty":-10.522122,"median":-2.089364,"eighty":-1.182279,"marketCap":15467765},{"date":"2024-11-15","current":-0.493189,"twenty":-10.383762,"median":-2.069928,"eighty":-1.172361,"marketCap":15720414},{"date":"2024-11-22","current":-0.727675,"twenty":-10.366889,"median":-2.063526,"eighty":-1.163203,"marketCap":23194640},{"date":"2024-11-29","current":-0.692883,"twenty":-10.333143,"median":-2.052343,"eighty":-1.153748,"marketCap":22085647},{"date":"2024-12-06","current":-0.682195,"twenty":-10.285898,"median":-2.047072,"eighty":-1.146883,"marketCap":21744975},{"date":"2024-12-13","current":-0.66082,"twenty":-10.120541,"median":-2.043874,"eighty":-1.13907,"marketCap":21063633},{"date":"2024-12-20","current":-0.546666,"twenty":-9.880941,"median":-2.034998,"eighty":-1.134188,"marketCap":17424974},{"date":"2024-12-27","current":-0.578502,"twenty":-9.786451,"median":-2.03022,"eighty":-1.134038,"marketCap":18439739},{"date":"2025-01-03","current":-0.63717,"twenty":-9.448987,"median":-2.021551,"eighty":-1.122855,"marketCap":20309807},{"date":"2025-01-10","current":-0.710847,"twenty":-9.408492,"median":-2.010187,"eighty":-1.116819,"marketCap":22658264},{"date":"2025-01-17","current":-0.674464,"twenty":-9.371371,"median":-2.008908,"eighty":-1.107887,"marketCap":21498532},{"date":"2025-01-24","current":-0.652179,"twenty":-9.364622,"median":-2.004072,"eighty":-1.101073,"marketCap":20788196},{"date":"2025-01-31","current":-0.563721,"twenty":-9.324126,"median":-2.001642,"eighty":-1.097961,"marketCap":17968598},{"date":"2025-02-07","current":-0.629894,"twenty":-9.287005,"median":-1.998049,"eighty":-1.084711,"marketCap":20077861},{"date":"2025-02-14","current":-0.734724,"twenty":-8.480466,"median":-1.989757,"eighty":-1.079412,"marketCap":23419339},{"date":"2025-02-21","current":-0.65036,"twenty":-7.873031,"median":-1.984857,"eighty":-1.069395,"marketCap":20730210},{"date":"2025-02-28","current":-0.576228,"twenty":-7.761668,"median":-1.963783,"eighty":-1.052376,"marketCap":18367256},{"date":"2025-03-07","current":-0.58828,"twenty":-7.74142,"median":-1.954613,"eighty":-1.046541,"marketCap":18751417},{"date":"2025-03-14","current":-0.514603,"twenty":-7.684052,"median":-1.94723,"eighty":-1.038248,"marketCap":16402960},{"date":"2025-03-21","current":-0.621782,"twenty":-7.576063,"median":-1.937378,"eighty":-1.029162,"marketCap":18925165},{"date":"2025-03-28","current":-0.555572,"twenty":-7.474824,"median":-1.932498,"eighty":-1.018376,"marketCap":16909948},{"date":"2025-04-04","current":-0.430361,"twenty":-7.454576,"median":-1.923725,"eighty":-1.015188,"marketCap":13098912},{"date":"2025-04-11","current":-0.392718,"twenty":-7.417455,"median":-1.910326,"eighty":-1.00529,"marketCap":11953164},{"date":"2025-04-17","current":-0.42075,"twenty":-7.400582,"median":-1.906138,"eighty":-0.992946,"marketCap":12806381},{"date":"2025-04-25","current":-0.493901,"twenty":-7.363461,"median":-1.902764,"eighty":-0.983856,"marketCap":15032871},{"date":"2025-05-02","current":-0.453588,"twenty":-7.316216,"median":-1.899535,"eighty":-0.976534,"marketCap":13805863},{"date":"2025-05-09","current":-0.497478,"twenty":-7.277408,"median":-1.883407,"eighty":-0.972926,"marketCap":13643346},{"date":"2025-05-16","current":-0.438552,"twenty":-7.228476,"median":-1.871872,"eighty":-0.963991,"marketCap":12027282},{"date":"2025-05-23","current":-0.439545,"twenty":-7.221726,"median":-1.86293,"eighty":-0.937651,"marketCap":12054514},{"date":"2025-05-30","current":-0.507727,"twenty":-7.221726,"median":-1.86244,"eighty":-0.918094,"marketCap":13924416},{"date":"2025-06-06","current":-0.452491,"twenty":-7.13736,"median":-1.85343,"eighty":-0.881988,"marketCap":12409571},{"date":"2025-06-13","current":-0.298898,"twenty":-7.120487,"median":-1.846259,"eighty":-0.836826,"marketCap":8197267},{"date":"2025-06-20","current":-0.267501,"twenty":-7.09349,"median":-1.844209,"eighty":-0.789983,"marketCap":7336209},{"date":"2025-06-27","current":-0.271268,"twenty":-7.086741,"median":-1.819939,"eighty":-0.773116,"marketCap":7439536},{"date":"2025-07-03","current":-0.27378,"twenty":-7.076617,"median":-1.803218,"eighty":-0.769837,"marketCap":7508421},{"date":"2025-07-11","current":-0.287595,"twenty":-7.039496,"median":-1.795936,"eighty":-0.758828,"marketCap":7887286},{"date":"2025-07-18","current":-0.276292,"twenty":-6.978752,"median":-1.788792,"eighty":-0.734997,"marketCap":7577306},{"date":"2025-07-25","current":-0.302665,"twenty":-6.951755,"median":-1.776194,"eighty":-0.730523,"marketCap":8300594},{"date":"2025-08-01","current":-0.267501,"twenty":-6.941631,"median":-1.775035,"eighty":-0.721671,"marketCap":7336209},{"date":"2025-08-08","current":-0.270013,"twenty":-6.924758,"median":-1.766314,"eighty":-0.708482,"marketCap":7405094},{"date":"2025-08-15","current":-0.456062,"twenty":-6.912947,"median":-1.751998,"eighty":-0.69467,"marketCap":10895320},{"date":"2025-08-22","current":-0.425658,"twenty":-6.894386,"median":-1.74829,"eighty":-0.690108,"marketCap":10168966},{"date":"2025-08-29","current":-0.429458,"twenty":-6.874138,"median":-1.748288,"eighty":-0.678245,"marketCap":10259760},{"date":"2025-09-05","current":-0.414256,"twenty":-6.853891,"median":-1.745515,"eighty":-0.665277,"marketCap":9896583},{"date":"2025-09-12","current":-0.397154,"twenty":-6.833643,"median":-1.732763,"eighty":-0.657272,"marketCap":9488008},{"date":"2025-09-19","current":-0.391453,"twenty":-6.826894,"median":-1.731089,"eighty":-0.65036,"marketCap":9351817},{"date":"2025-09-26","current":-0.397154,"twenty":-6.81677,"median":-1.722809,"eighty":-0.632804,"marketCap":9488008},{"date":"2025-10-03","current":-0.435159,"twenty":-6.796522,"median":-1.719628,"eighty":-0.622116,"marketCap":10395951},{"date":"2025-10-10","current":-0.44276,"twenty":-6.67166,"median":-1.703635,"eighty":-0.615477,"marketCap":10577540},{"date":"2025-10-17","current":-0.400954,"twenty":-6.506303,"median":-1.696672,"eighty":-0.61102,"marketCap":9578802},{"date":"2025-10-24","current":-0.399054,"twenty":-6.4135,"median":-1.691412,"eighty":-0.608649,"marketCap":9533405},{"date":"2025-10-31","current":-0.378151,"twenty":-6.313949,"median":-1.683139,"eighty":-0.604743,"marketCap":9034036},{"date":"2025-11-07","current":-0.315443,"twenty":-6.192462,"median":-1.674883,"eighty":-0.589735,"marketCap":7535930},{"date":"2025-11-14","current":-0.367916,"twenty":-5.748368,"median":-1.661586,"eighty":-0.581385,"marketCap":7600409},{"date":"2025-11-21","current":-0.356699,"twenty":-5.517534,"median":-1.651636,"eighty":-0.574045,"marketCap":7368689},{"date":"2025-11-28","current":-0.444191,"twenty":-5.410942,"median":-1.632125,"eighty":-0.562811,"marketCap":9176104},{"date":"2025-12-05","current":-0.408297,"twenty":-5.264324,"median":-1.607126,"eighty":-0.54994,"marketCap":8434600},{"date":"2025-12-12","current":-0.388107,"twenty":-4.859526,"median":-1.601257,"eighty":-0.523633,"marketCap":8017505},{"date":"2025-12-19","current":-0.309588,"twenty":-4.516588,"median":-1.590655,"eighty":-0.504443,"marketCap":6395466},{"date":"2025-12-26","current":-0.448678,"twenty":-4.408744,"median":-1.586832,"eighty":-0.493616,"marketCap":9268792},{"date":"2026-01-02","current":-0.524953,"twenty":-4.3009,"median":-1.576798,"eighty":-0.492778,"marketCap":10844486},{"date":"2026-01-09","current":-0.538414,"twenty":-4.20076,"median":-1.549256,"eighty":-0.492778,"marketCap":11122550},{"date":"2026-01-16","current":-0.520467,"twenty":-3.985073,"median":-1.525665,"eighty":-0.489933,"marketCap":10751798},{"date":"2026-01-23","current":-1.172427,"twenty":-3.461262,"median":-1.514703,"eighty":-0.489933,"marketCap":24220007},{"date":"2026-01-30","current":-0.945506,"twenty":-3.213353,"median":-1.500277,"eighty":-0.489933,"marketCap":19532264},{"date":"2026-02-06","current":-0.898231,"twenty":-3.059247,"median":-1.493809,"eighty":-0.489933,"marketCap":18555650},{"date":"2026-02-13","current":-0.874593,"twenty":-2.940606,"median":-1.482493,"eighty":-0.489933,"marketCap":18067344},{"date":"2026-02-20","current":-0.756405,"twenty":-2.856833,"median":-1.474701,"eighty":-0.489933,"marketCap":15625811},{"date":"2026-02-27","current":-0.808408,"twenty":-2.761853,"median":-1.464198,"eighty":-0.489933,"marketCap":16700085},{"date":"2026-03-06","current":-0.82259,"twenty":-2.706977,"median":-1.452462,"eighty":-0.489933,"marketCap":16993069},{"date":"2026-03-13","current":-0.902958,"twenty":-2.643071,"median":-1.446342,"eighty":-0.490225,"marketCap":18653312},{"date":"2026-03-20","current":-0.871244,"twenty":-2.637064,"median":-1.442574,"eighty":-0.491833,"marketCap":16936993}],"updateTime":1774307912749},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INAB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620047333","title":"IN8BIO Inc. publishes corporate presentation on gamma-delta T cell therapies in oncology and autoimmune diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2620047333","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620047333?lang=en_us&edition=fundamental","pubTime":"2026-03-17 22:10","pubTimestamp":1773756618,"startTime":"0","endTime":"0","summary":"IN8bio outlined its focus on developing gamma-delta T cell therapies and T cell engagers for oncology and autoimmune diseases. The presentation said its lead glioblastoma programs, INB-200 and INB-400, are being evaluated as a drug-resistant immunotherapy approach alongside temozolomide and radiation. IN8bio reported that 17 patients were treated with DRI gamma-delta T cells and 10 patients were observed in a contemporaneous control arm across four centers before enrollment was suspended in 2024. It also reported no major toxicity signals or significant adverse events across sites or treatment arms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief on March 17, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLbBmRHb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2619194089","title":"IN8bio Price Target Maintained With a $6.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194089?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:11","pubTimestamp":1773403860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INAB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2026 08:11 ET (12:11 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2619152748","title":"IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619152748","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619152748?lang=en_us&edition=fundamental","pubTime":"2026-03-13 04:01","pubTimestamp":1773345660,"startTime":"0","endTime":"0","summary":"Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, with repeat dosing of DeltEx Drug-Resistant Immunotherapy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/12/3255081/0/en/IN8bio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Highlights-Durable-Survival-Improvements-in-Glioblastoma-Advancing-Pipeline-and-Strengthened-Financial-Position-f.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2614860323","title":"IN8bio Inc  expected to post a loss of 62 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2614860323","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614860323?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:55","pubTimestamp":1772229304,"startTime":"0","endTime":"0","summary":"IN8bio Inc  expected to post a loss of62cents a share - Earnings Preview IN8bio Inc INAB.OQ INAB.O is expected to  show no change in quarterly revenue when it reports  results on March 2 (estimated) f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL8N3ZN2U2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2614860690","title":"IN8bio Announces Board Resignation and Interim Chair Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2614860690","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614860690?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:42","pubTimestamp":1772228532,"startTime":"0","endTime":"0","summary":"IN8bio ( ($INAB) ) has shared an update. On February 26, 2026, IN8bio, Inc. announced that director Alan S. Roemer had notified the Board of his de...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/in8bio-announces-board-resignation-and-interim-chair-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/in8bio-announces-board-resignation-and-interim-chair-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2614621108","title":"IN8bio Inc - Jeremy Graff Appointed Interim Chair of Board - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614621108","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614621108?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:09","pubTimestamp":1772226586,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZN29Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2614486211","title":"IN8bio Inc - Alan S. Roemer Resigns as Director of IN8bio - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614486211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614486211?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:09","pubTimestamp":1772226586,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZN29Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2614886211","title":"IN8bio Names Jeremy Graff Interim Board Chair as Alan Roemer Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2614886211","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614886211?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:08","pubTimestamp":1772226539,"startTime":"0","endTime":"0","summary":"IN8bio said director Alan S. Roemer will resign from the board and step down from its Audit and Compensation Committees effective February 28, 2026. The company appointed independent director Jeremy Graff as interim chair of the board effective the same date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL65sWCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2610584666","title":"IN8BIO ernennt Kate Rochlin zur Präsidentin und Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610584666","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610584666?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642055,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. hat die Befrderung von Kate Rochlin, Ph.D., zur Prsidentin und Chief Operating Officer bekannt gegeben. Rochlin war zuvor als Chief Operating Officer ttig und übernimmt ab sofort die erweiterte Führungsrolle.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via GlobeNewswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL7YjBb3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","LU0314104364.USD","BK4539","BK4588","INAB","SG9999014005.SGD","BK4139","SG9999014021.USD","BK4112","SG9999014039.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","SG9999014013.SGD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2610582656","title":"Press Release: IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610582656","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610582656?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642000,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 09, 2026  -- IN8bio , a clinical-stage biopharmaceutical company developing innovative gamma-delta  T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced the promotion of Kate Rochlin, Ph.D., to President and Chief Operating Officer, effective immediately.Dr. Rochlin has served as IN8bio's Chief Operating Officer since December 2021, following her tenure as Vice President and Associate Vice President of Operations and Innovation beginning in August 2020. In her expanded role, she will continue to oversee company operations as IN8bio advances its clinical and preclinical pipeline and prepares for its next phase of growth.\"I'm honored to take on this expanded role and broader leadership responsibilities at such an important time for IN8bio,\" said Dr. Rochlin. \"With encouraging clinical data emerging from our <GAMMA> T cell therapy programs and novel gamma-delta T cell engager technology, we are well positioned to build on this momentum. I","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"gpt_icon":0},{"id":"2608879393","title":"IN8BIO Showcases DeltEx Immunotherapy Results at IO360° Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879393","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879393?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123665,"startTime":"0","endTime":"0","summary":"IN8BIO Inc., a clinical-stage biopharmaceutical company developing gamma-delta T cell therapies, will participate in the Noble Emerging Growth Virtual Equity Conference on February 5, 2026, at 3:00 p.m. ET. Additionally, the company will present at the IO360° Conference on February 12, 2026, from 1:20 p.m. to 1:40 p.m. ET, where CEO William Ho will discuss IN8bio's DeltEx Drug Resistant Immunotherapy approach and results from a Phase 1/2 study in newly diagnosed glioblastoma multiforme . Further details and webcast information will be available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDLRCSZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BGHQF748.EUR","BK4112","SG9999014005.SGD","BK4588","SG9999014013.SGD","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","BK4539","SG9999014039.USD","IE00BKPKM429.USD","BK4585","INAB","LU2095319765.USD","BK4139"],"gpt_icon":0},{"id":"2608879310","title":"IN8BIO präsentiert neue Ergebnisse zur Immuntherapie gegen solide Tumoren auf Fachkonferenzen","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879310","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879310?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123664,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. wird am 5. Februar 2026 am Noble Emerging Growth Virtual Equity Conference teilnehmen. Zudem prsentiert das Unternehmen am 12. Februar 2026 auf der IO360° Conference neueste Ergebnisse zur DeltEx Drug Resistant Immunotherapy  bei soliden Tumoren und aus einer Phase-1/2-Studie bei neu diagnostiziertem Glioblastoma multiforme .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDLJCmd3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IE00B3QW5Z07.USD","BK4588","BK4585","INAB","SG9999014039.USD","SG9999014021.USD","BK4139","SG9999014013.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","NDAQ","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","LU0314104364.USD","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD"],"gpt_icon":0},{"id":"2605147020","title":"IN8bio (INAB) Receives a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2605147020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605147020?lang=en_us&edition=fundamental","pubTime":"2026-01-23 20:51","pubTimestamp":1769172679,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on IN8bio, with a price target of $5.00. Roy covers the Healthcare...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/in8bio-inab-receives-a-buy-from-jonestrading-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/in8bio-inab-receives-a-buy-from-jonestrading-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4139","XLV","XBI","BK4585","BK4581","BK4539","INAB"],"gpt_icon":0},{"id":"2605313142","title":"IN8bio files to sell 14.38M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2605313142","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605313142?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:00","pubTimestamp":1768946429,"startTime":"0","endTime":"0","summary":"16:57 EST IN8bio (INAB) files to sell 14.38M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mark...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-files-to-sell-14-38m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-files-to-sell-14-38m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2604914970","title":"IN8BIO Inc. unveils presentation on advancing gamma-delta T cell therapies for cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2604914970","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604914970?lang=en_us&edition=fundamental","pubTime":"2026-01-17 06:31","pubTimestamp":1768602697,"startTime":"0","endTime":"0","summary":"IN8BIO Inc. has released a corporate presentation detailing advances in its pipeline focused on gamma-delta (γδ) T cell therapies. The update highlights ongoing clinical and preclinical programs, including the DeltEx platform for acute myeloid leukemia  and glioblastoma , with ongoing patient dosing and upcoming clinical updates projected for late 2026. The presentation also outlines research into non-signaling CAR-T cells, induced pluripotent stem cell -derived T cells, and T cell engagers for potential applications in oncology and autoimmune diseases. Additional data on completed trials and plans for regulatory engagement with the FDA are provided. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL3nwRVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2603611902","title":"IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603611902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603611902?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:56","pubTimestamp":1768398968,"startTime":"0","endTime":"0","summary":"In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on IN8bio, with a price target of $6.00. Swayampaku...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/in8bio-clinical-momentum-strengthened-cash-runway-and-unmodeled-pipeline-upside-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/in8bio-clinical-momentum-strengthened-cash-runway-and-unmodeled-pipeline-upside-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB"],"gpt_icon":0},{"id":"2602752548","title":"IN8bio presents Phase I/II data from INB-200 trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2602752548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602752548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:35","pubTimestamp":1768224956,"startTime":"0","endTime":"0","summary":"IN8bio (INAB) reported updated clinical data from its INB-200 Phase 1 and INB-400 Phase 2 trials in newly diagnosed glioblastoma. The prior results...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-presents-phase-i-ii-data-from-inb-200-trials-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-presents-phase-i-ii-data-from-inb-200-trials-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INB","BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2602510263","title":"IN8bio Inc - Delttex Immunotherapy Doubles Median Progression-Free Survival to 13 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510263","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510263?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223745,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0DB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2602251025","title":"IN8bio Inc - Delttex Treatment Shows No Severe Adverse Events or Toxicities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602251025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602251025?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223745,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0DB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2602510848","title":"IN8bio Gamma-Delta T Cell Therapy Nearly Doubles Progression-Free Survival in Glioblastoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510848","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510848?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:01","pubTimestamp":1768222878,"startTime":"0","endTime":"0","summary":"IN8bio, Inc. has announced updated clinical data from its INB-200 Phase 1 and INB-400 Phase 2 trials evaluating DeltEx Drug-Resistant Immunotherapy  gamma-delta (γδ) T cells in newly diagnosed glioblastoma . The results were presented at the 2025 Society for Neuro-Oncology  Annual Meeting. The data showed that repeat-doses of DeltEx DRI γδ T cells nearly doubled median progression-free survival  to 13.0 months compared to 6.6 months in a standard-of-care  control cohort. Median overall survival  was reported at 17.2+ months as of December 31, 2025, compared to 13.2 months for SOC. The treatment demonstrated a favorable safety profile, with no treatment-related severe adverse events or dose limiting toxicities observed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL6bfg4T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00B64PRP62.GBP","SG9999014005.SGD","BK4539","SG9999014021.USD","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","LU2210150020.SGD","INAB","IE00B3QW5Z07.USD","BK4112","BK4588","BK4139","IE00BGHQF748.EUR"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}]}}